Rocket Lab Valuation Risk

Conviction: 73% · Horizon: 1Y · 2026-05-20
Extreme sales multiples make further position reduction attractive.

Rocket Lab trades at a price-to-sales ratio above 100, leaving little room for execution risk, multiple compression, or slower growth. Reducing exposure locks in gains and increases cash available for opportunities with better risk-adjusted return potential.

Instrument Side Target Reason
RKLB Sell A price-to-sales multiple above 100 creates an asymmetric setup where even strong operating progress may not justify the valuation. Trimming the position monetizes a large gain and reduces exposure to a sharp rerating.

Themes

The content on this page is for informational purposes only and does not constitute financial advice. Stoquate is not a licensed financial advisor. Always conduct your own research and consult a qualified professional before making any investment decisions.